BBM/Aesculap AG

Relevant Expertise/Experience
• Design, manufacture and marketing of medical devices including artificial joint
• Compliance with the regulatory requirements
• Commercialisation of medical devices
• Exploitation through commercialisation

Role in the project
• Provision of test specimens for pre-clinical testing of coating
• Advice on the regulatory and exploitation plan
• Testing of the prototype prostheses
• Exploitation through (a) standards and (b) device commercialisation

Aesculap AG (AAG): B. Braun is one of the world’s leading suppliers of healthcare products. Its four divisions orient their products and services toward different medical fields: hospital, surgery, private practice (medical care and doctors’ offices) and extracorporeal blood treatment. By networking the divisions’ knowledge and developing solutions for the healthcare system, the company transforms products and services into integrated systems. B. Braun’s Aesculap Division focuses on products and services for all of the core processes in surgery.

Aesculap Division’s headquarters are in Tuttlingen, Germany, where it has about 3,100 employees. Internationally, Aesculap has about 9,000 personnel, and production sites all over the world. Its product range includes surgical instruments for open or minimally invasive approaches, implants, surgical sutures, sterile container, storage, motor and navigation systems, as well as products for cardiology. Aesculap is the market leader in CT-free navigation and offers a comprehensive system for precise implantation in hip and knee surgeries. The benefit to the patient is central to the development of less invasive, bone-preserving implantation techniques and the consistent use of biocompatible materials.

Partner contribution
AAG provides test specimens for pre-clinical testing of coating, advice on the regulatory and exploitation plan, testing of the prototype prostheses, and exploitation through standards and device commercialisation.